Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
AstraZeneca
McKinsey
Merck
Express Scripts

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for LEVETIRACETAM

See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for LEVETIRACETAM (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
INSIDE ANOTHER STORE $7,981,422
INSIDE HMO/CLINIC/HOSPITAL $15,226,561
[disabled in preview] $3,459,381
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
INSIDE ANOTHER STORE 113,754
INSIDE HMO/CLINIC/HOSPITAL 285,550
[disabled in preview] 90,347
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICARE $8,652,459
OTHER FEDERAL $304,368
[disabled in preview] $17,710,538
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for LEVETIRACETAM
Drug Units Sold Trends for LEVETIRACETAM

Annual Sales Revenues and Units Sold for LEVETIRACETAM

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
LEVETIRACETAM   Start Trial   Start Trial 2017
LEVETIRACETAM   Start Trial   Start Trial 2016
LEVETIRACETAM   Start Trial   Start Trial 2015
LEVETIRACETAM   Start Trial   Start Trial 2014
LEVETIRACETAM   Start Trial   Start Trial 2013
LEVETIRACETAM   Start Trial   Start Trial 2012
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Baxter
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.